Cargando…
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
Immunotherapy has revolutionized the treatment of cancer. Nevertheless, the majority of patients do not respond to therapy, meaning a deeper understanding of tumor immune evasion strategies is required to boost treatment efficacy. The vast majority of immunotherapy studies have focused on how treatm...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538772/ https://www.ncbi.nlm.nih.gov/pubmed/33072137 http://dx.doi.org/10.3389/fimmu.2020.589641 |